Every few years, Washington finds a new healthcare villain – drug manufacturers, PBMs, insurers, or hospitals. Hearings are held, headlines are written, and promises of reform are made; yet the underlying problems persist. In his latest op-ed for DC Journal, Managing Partner Michael Abrams argues that healthcare’s biggest challenge isn’t cost – it’s accountability.

When every stakeholder points fingers at someone else, consumers are left without a voice, prices remain opaque, and incentives continue to reward revenue over value. The administration’s renewed focus on hospital price transparency is a step in the right direction, but transparency alone won’t fix a system that has spent decades rewarding opacity and cost shifting. Real reform requires changing the incentives through meaningful accountability, better data on quality and outcomes, and enforcement with real consequences.

Read his full feature piece here.